Akanda Corp Trading Halted, News Pending
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 10 2026
0mins
Akanda Corp trading halted, news pending
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AKAN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AKAN
About AKAN
Akanda Corp. is a United Kingdom-based company, which is focused on the growth of its Canadian farming property in British Columbia. The Company plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Akanda (AKAN) Signs $7M Private Placement Deal Expected to Close by January 21, 2026
- Funding Initiative: Akanda is set to raise $7 million through a 12-month convertible promissory note private placement with institutional investors, aimed at bolstering marketing efforts, working capital, and general corporate needs, thereby enhancing financial flexibility.
- Debt Repayment: The proceeds will be allocated towards debt repayment, which is expected to improve the company's capital structure, reduce financial risk, and enhance future financing capabilities.
- Reverse Stock Split: Akanda has announced a 1-for-5 reverse stock split intended to increase the share price, attract more investor interest, and improve market liquidity.
- Market Outlook: The transaction is expected to close by January 21, 2026, and if successfully executed, will provide the necessary funding support to help achieve the company's long-term strategic objectives.
Continue Reading
Dow Gains More Than 100 Points as Lululemon Reports Strong Q3 Earnings
Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining 0.24% while the NASDAQ and S&P 500 fell by 0.34% and 0.13%, respectively.
Lululemon's Strong Earnings: Lululemon Athletica reported better-than-expected third-quarter earnings of $2.59 per share, surpassing estimates, and raised its full-year guidance.
Notable Stock Movements: cbdMD Inc shares surged 101% after compliance news, while Applied Therapeutics Inc saw a 48% drop following acquisition plans.
Global Market Trends: European and Asian markets closed higher, with the eurozone's STOXX 600 up 0.2% and Japan's Nikkei gaining 1.37%.
Continue Reading